Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • 2020
  • Working Paper

What Can Economics Say About Alzheimer's Disease?

By: Amitabh Chandra, Courtney Coile and Corina Mommaerts
  • Language:English
ShareBar

Abstract

Alzheimer’s Disease (AD) affects one in ten people aged 65 or older and is the most expensive disease in the United States. We describe the central economic questions raised by AD. While there is overlap with the economics of aging, the defining features of the ‘economics of Alzheimer’s Disease’ is an emphasis on cognitive decline, choice by cognitively impaired patients, and a host of issues where dynamic contracts between patients and caregivers are hard to enforce. There is enormous scope for economists to contribute to our understanding of AD-related issues, including drug development, efficient care delivery, dynamic contracting within the family and with care providers, long-term care risk, financial decision-making, and public programs for AD. These topics overlap with many areas of economics—labor economics, health economics, public finance, behavioral economics, experimental economics, family economics, mechanism design, and the economics of innovation—suggesting the presence of a rich research program that should attract many economists.

Keywords

Health Disorders; Health Care and Treatment; Economics

Citation

Chandra, Amitabh, Courtney Coile, and Corina Mommaerts. "What Can Economics Say About Alzheimer's Disease?" NBER Working Paper Series, No. 27760, August 2020.
  • Read Now

About The Author

Amitabh Chandra

Technology and Operations Management
→More Publications

More from the Authors

    • December 2021
    • Faculty Research

    Value-Based Insurance Design at Onex

    By: Joshua Schwartzstein, Amitabh Chandra and Amram Migdal
    • New England Journal of Medicine

    Supporting Value-Based Health Care—Aligning Financial and Legal Accountability

    By: Mark M. Zaki, Anupam B. Jena and Amitabh Chandra
    • June 2021
    • Faculty Research

    Who Lives & Who Dies: Expanded Access for Experimental Drugs at Chimerix (B)

    By: Amitabh Chandra and Spencer Lee-Rey
More from the Authors
  • Value-Based Insurance Design at Onex By: Joshua Schwartzstein, Amitabh Chandra and Amram Migdal
  • Supporting Value-Based Health Care—Aligning Financial and Legal Accountability By: Mark M. Zaki, Anupam B. Jena and Amitabh Chandra
  • Who Lives & Who Dies: Expanded Access for Experimental Drugs at Chimerix (B) By: Amitabh Chandra and Spencer Lee-Rey
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College